BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/14/2021 4:10:47 AM | Browse: 103 | Download: 146
Publication Name World Journal of Transplantation
Manuscript ID 62228
Country France
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Transplantation of CD34+ cells for myocardial ischemia
Manuscript Source Invited Manuscript
All Author List Anthony Matta, Vanessa Nader, Michel Galinier and Jerome Roncalli
Funding Agency and Grant Number
Corresponding Author Jerome Roncalli, MD, PhD, Full Professor, Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, 1 Avenue Jean Poulhès, Toulouse 31059, France. roncalli.j@chu-toulouse.fr
Key Words Cell therapy; Endothelial progenitor cells; Myocardial ischemia; Refractory angina; Heart failure; Coronary microvascular dysfunction
Core Tip CD34+ cells are mobilized from the bone marrow into the peripheral circulation in response to ischemic tissue injury. Once they migrate to the target site, they enhance angiogenesis, neovascularization and tissue regeneration. Safety and efficacy of CD34+ cell transplantation has been investigated in order to limit left ventricular dysfunction after acute myocardial infarction, refractory angina and heart failure.
Citation Matta A, Nader V, Galinier M, Roncalli J. Transplantation of CD34+ cells for myocardial ischemia. World J Transplant 2021; 11(5): 138-146
Received
2021-01-29 08:13
Peer-Review Started
2021-01-29 08:25
To Make the First Decision
Return for Revision
2021-02-25 02:45
Revised
2021-03-01 16:49
Second Decision
2021-04-08 12:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-14 04:10
Articles in Press
2021-04-14 04:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-05-14 02:10
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com